Cyclacel Pharmaceuticals, Inc. (BGMS)
Market Closed
15 Oct, 08:00 PM
NASDAQ (NMS) NASDAQ (NMS) Primary $
0. 83
-0.06
-6.9201%
Pre Market
$
+0.08 +9.2722% 0. 91
4.53M Market Cap
- P/E Ratio
- Div Yield
15,026 Volume
- Eps
$ 0.89
Previous Close Want to track BGMS and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Cyclacel Pharmaceuticals, Inc. (BGMS) Statistics
Valuation metrics
Market Cap 4.53M
Enterprise value 896.02K
Trailing P/E (ttm) -0.23
Forward P/E -
PEG ratio -0
Price/Sales (ttm) 2.52
Price/Book (mrq) 0.66
Enterprise Value/Revenue 0.48
Enterprise Value/EBITDA -0.33
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 10.51K
Average volume (90 days) 72.89K
Price summary
52-Week low 0.57
52-Week high 5.79
Beta -
50-Day moving average 0.89
200-Day moving average 0.94
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -0.03
Dividend Date -
Ex-Dividend Date -
Last split factor 1:15
Last split Date 7 Jul 2025
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -1.18%
Operating margin -1.47%
Operational effectiveness
Return on assets -0.28%
Return on equity -0.32%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 0.33
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -0.39
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 0.68
Total debt (mrq) -
Total Debt/Equity (mrq) -
Current ratio (mrq) 8.63%
Book value per share (mrq) 1.28
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
2026 © Marketlog. All Rights Reserved.
